Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia
Authors
Keywords
-
Journal
International Journal of Pharmacology
Volume 19, Issue 4, Pages 585-594
Publisher
Science Alert
Online
2023-10-21
DOI
10.3923/ijp.2023.585.594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic strategies for COVID-19: progress and lessons learned
- (2023) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease
- (2023) Mohammad El-Sayed et al. Arab Journal of Gastroenterology
- Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
- (2022) Queenie Fernandes et al. ANNALS OF MEDICINE
- Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
- (2022) Yusha Araf et al. JOURNAL OF MEDICAL VIROLOGY
- Mechanisms of opioid-induced respiratory depression
- (2022) Brian A. Baldo et al. ARCHIVES OF TOXICOLOGY
- Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship
- (2022) Damiano D’Ardes et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The clinical application progress and potential of drug-induced sleep endoscopy in obstructive sleep apnea
- (2022) Alonço Viana et al. ANNALS OF MEDICINE
- Management of oliguria
- (2022) Marlies Ostermann et al. INTENSIVE CARE MEDICINE
- Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence
- (2021) Sayeeda Rahman et al. Expert Review of Clinical Pharmacology
- Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit
- (2021) Guobin Xia et al. MOLECULAR PSYCHIATRY
- Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis
- (2021) Mulugeta T. Angamo et al. INFECTION
- A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
- (2021) Lauren Forchette et al. Current Medical Science
- “Compassion Cannot Choose:” A Call for Family-centered Critical Care during the COVID-19 Pandemic
- (2021) Midhun Mohan et al. Indian Journal of Critical Care Medicine
- Diagnostics for COVID-19: moving from pandemic response to control
- (2021) Rosanna W Peeling et al. LANCET
- Obstructive Lung Disease and Obstructive Sleep Apnea (OLDOSA) cohort study: 10-year assessment
- (2020) Octavian C. Ioachimescu et al. Journal of Clinical Sleep Medicine
- Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)
- (2020) François Montastruc et al. Clinical Gastroenterology and Hepatology
- Drug reaction, eosinophilia, and systemic symptoms (DRESS) syndrome
- (2020) Adela R. Cardones CLINICS IN DERMATOLOGY
- Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
- (2020) Zita-Rose Manjaly Thomas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of favipiravir in the treatment of COVID-19
- (2020) Shashank Joshi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Constipation, diarrhea, and prophylactic laxative bowel regimens in the critically ill: A systematic review and meta-analysis
- (2019) Tyler Hay et al. JOURNAL OF CRITICAL CARE
- Neurological and Psychiatric Adverse Effects of Antimicrobials
- (2019) Madison K. Bangert et al. CNS DRUGS
- Drug-associated pulmonary arterial hypertension
- (2018) Michael McGee et al. CLINICAL TOXICOLOGY
- Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C
- (2015) Yousef Fazel et al. Expert Opinion On Drug Safety
- The role of quantitative safety evaluation in regulatory decision making of drugs
- (2015) Aloka G. Chakravarty et al. Journal of Biopharmaceutical Statistics
- Antiviral Drug Allergy
- (2014) Brigitte Milpied-Homsi et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Medication Reconciliation During Transitions of Care as a Patient Safety Strategy
- (2013) Janice L. Kwan* et al. ANNALS OF INTERNAL MEDICINE
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management
- (2013) Henry A. Spiller et al. CNS DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started